Form 4: Co-Diagnostics CEO Dwight Egan Reports Stock Transactions
SEC Form 4
CEO Dwight Egan reports acquisition of 138,333 shares via restricted stock units and disposition of 42,008 shares to cover tax obligations.
Summary
- On May 23, 2024, Dwight H. Egan, CEO of Co-Diagnostics, Inc., acquired 138,333 shares of common stock through the vesting of restricted stock units (RSUs).
- The acquisition price for these shares was $0.00.
- On the same day, Egan disposed of 42,008 shares at a price of $1.09 per share to cover tax withholding obligations related to the vesting of the RSUs.
- Following these transactions, Egan directly owns 367,206 shares of Co-Diagnostics common stock.
- Egan also holds 627,500 derivative securities in the form of restricted stock units.
Sentiment
Score: 5
Explanation: The document reports routine stock transactions related to executive compensation. It doesn't inherently indicate positive or negative sentiment.
Industry Context
Executive stock transactions are a routine part of corporate governance and are closely watched by investors for insights into management's perspective on the company's value and future prospects.
Stakeholder Impact
- Shareholders may be interested in the CEO's stock transactions as an indicator of confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 08/12/2021 | 125,000 restricted stock units awarded, vesting in 6 equal installments every 6 months commencing on November 23, 2021. |
| 11/23/2021 | Commencement of vesting for 125,000 restricted stock units awarded on August 12, 2021. |
| 06/06/2022 | 275,000 restricted stock units awarded, vesting in 6 equal installments every 6 months commencing on November 23, 2022. |
| 11/23/2022 | Commencement of vesting for 275,000 restricted stock units awarded on June 6, 2022. |
| 01/17/2023 | 155,000 restricted stock units awarded, vesting in 6 equal installments every 6 months commencing on May 23, 2023. |
| 05/15/2023 | 275,000 restricted stock units awarded, vesting in 6 equal installments every 6 months commencing on November 23, 2023. |
| 05/23/2023 | Commencement of vesting for 155,000 restricted stock units awarded on January 17, 2023. |
| 11/23/2023 | Commencement of vesting for 275,000 restricted stock units awarded on May 15, 2023. |
| 05/23/2024 | Date of reported transactions: acquisition of 138,333 shares via RSU vesting and disposition of 42,008 shares for tax obligations. |
| 05/28/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.